,GO,Description,Group,Enrichment.cGSC,EnrichmentCoreMinus1,Enrichment.Positive.GiPSC,Enrichment.Negative.GiPSC,Number.of.0s,Mean.of.both.enrichments,EnrichmentMinus1,Neg.cGSC,Neg.GIPSC,Log2cGSC,Log2GIPSC
526,GO:0051258,protein polymerization,Cytoskeleton,-4.7,-3.7,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-2.232660757,-0.378511623
572,GO:0005925,focal adhesion,Cytoskeleton,-5.3,-4.3,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.40599236,-1.201633861
575,GO:0032271,regulation of protein polymerization,Cytoskeleton,-5.4,-4.4,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.432959407,-0.263034406
588,GO:0032273,positive regulation of protein polymerization,Cytoskeleton,-5.6,-4.6,0,-1,1,-1,0,Negativo,Negativo,-2.485426827,0
610,GO:0032272,negative regulation of protein polymerization,Cytoskeleton,-6,-5,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.584962501,-0.263034406
621,GO:0097581,lamellipodium organization,Cytoskeleton,-6.2,-5.2,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-2.632268215,-0.765534746
631,GO:0030032,lamellipodium assembly,Cytoskeleton,-6.5,-5.5,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.700439718,-0.847996907
552,GO:0005884,actin filament,Cytoskeleton,-5.1,-4.1,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.350497247,-0.678071905
380,GO:0019894,kinesin binding,Cytoskeleton,7.9,6.9,0,-2.3,1,-2.3,-1.3,Positivo,Negativo,2.981852653,-1.201633861
401,GO:0032272,negative regulation of protein polymerization,Cytoskeleton,5.8,4.8,0,-1.2,1,-1.2,-0.2,Positivo,Negativo,2.5360529,-0.263034406
417,GO:0099513,polymeric cytoskeletal fiber,Cytoskeleton,2.3,1.3,0,-1.5,1,-1.5,-0.5,Positivo,Negativo,1.201633861,-0.584962501
525,GO:0051495,positive regulation of cytoskeleton organization,Cytoskeleton,-4.7,-3.7,1.1,0,1,1.1,0.1,Negativo,Positivo,-2.232660757,0.137503524
685,GO:2000249,regulation of actin cytoskeleton reorganization,Cytoskeleton,-7.7,-6.7,1.8,0,1,1.8,0.8,Negativo,Positivo,-2.944858446,0.847996907
402,GO:0046785,microtubule polymerization,Cytoskeleton,5.4,4.4,1.1,0,1,1.1,0.1,Positivo,Positivo,2.432959407,0.137503524
448,GO:0051701,biological process involved in interaction with host,Immunity,-3.1,-2.1,0,-2,1,-2,-1,Negativo,Negativo,-1.632268215,-1
465,GO:0071219,cellular response to molecule of bacterial origin,Immunity,-3.5,-2.5,0,-3.9,1,-3.9,-2.9,Negativo,Negativo,-1.807354922,-1.963474124
801,GO:0098581,detection of external biotic stimulus,Immunity,-21,-20,0,-4.2,1,-4.2,-3.2,Negativo,Negativo,-4.392317423,-2.070389328
802,GO:0098543,detection of other organism,Immunity,-22,-21,0,-3.9,1,-3.9,-2.9,Negativo,Negativo,-4.459431619,-1.963474124
810,GO:0016045,detection of bacterium,Immunity,-27,-26,0,-3,1,-3,-2,Negativo,Negativo,-4.754887502,-1.584962501
811,GO:0075294,positive regulation by symbiont of entry into host,Immunity,-27,-26,0,-3.6,1,-3.6,-2.6,Negativo,Negativo,-4.754887502,-1.847996907
443,GO:0032103,positive regulation of response to external stimulus,Immunity,-3,-2,0,-2,1,-2,-1,Negativo,Negativo,-1.584962501,-1
444,GO:0050727,regulation of inflammatory response,Immunity,-3,-2,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-1.584962501,-1.137503524
449,GO:0006954,inflammatory response,Immunity,-3.1,-2.1,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-1.632268215,-1.201633861
450,GO:0034612,response to tumor necrosis factor,Immunity,-3.1,-2.1,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-1.632268215,-1.321928095
452,GO:0042113,B cell activation,Immunity,-3.2,-2.2,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-1.678071905,-0.925999419
456,GO:0031347,regulation of defense response,Immunity,-3.2,-2.2,0,-2,1,-2,-1,Negativo,Negativo,-1.678071905,-1
459,GO:0031349,positive regulation of defense response,Immunity,-3.2,-2.2,0,-2,1,-2,-1,Negativo,Negativo,-1.678071905,-1
462,GO:0045089,positive regulation of innate immune response,Immunity,-3.3,-2.3,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-1.722466024,-0.584962501
474,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,Immunity,-3.6,-2.6,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-1.847996907,-1.201633861
477,GO:0002833,positive regulation of response to biotic stimulus,Immunity,-3.8,-2.8,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-1.925999419,-0.765534746
479,GO:0038061,NIK/NF-kappaB signaling,Immunity,-3.8,-2.8,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-1.925999419,-1.201633861
483,GO:0001818,negative regulation of cytokine production,Immunity,-3.9,-2.9,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-1.963474124,-1.137503524
485,GO:0032635,interleukin-6 production,Immunity,-3.9,-2.9,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-1.963474124,-1.432959407
486,GO:0030099,myeloid cell differentiation,Immunity,-4,-3,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2,-0.678071905
488,GO:0046649,lymphocyte activation,Immunity,-4,-3,0,-2,1,-2,-1,Negativo,Negativo,-2,-1
489,GO:0002831,regulation of response to biotic stimulus,Immunity,-4,-3,0,-2,1,-2,-1,Negativo,Negativo,-2,-1
492,GO:0045637,regulation of myeloid cell differentiation,Immunity,-4.1,-3.1,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-2.03562391,-0.378511623
503,GO:0032675,regulation of interleukin-6 production,Immunity,-4.1,-3.1,0,-2.8,1,-2.8,-1.8,Negativo,Negativo,-2.03562391,-1.485426827
512,GO:0051249,regulation of lymphocyte activation,Immunity,-4.3,-3.3,0,-2,1,-2,-1,Negativo,Negativo,-2.10433666,-1
513,GO:0002220,innate immune response activating cell surface receptor signaling pathway,Immunity,-4.4,-3.4,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.137503524,-0.263034406
515,GO:0002758,innate immune response-activating signal transduction,Immunity,-4.4,-3.4,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.137503524,-0.263034406
520,GO:0002694,regulation of leukocyte activation,Immunity,-4.5,-3.5,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.169925001,-0.925999419
528,GO:0050851,antigen receptor-mediated signaling pathway,Immunity,-4.7,-3.7,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-2.232660757,-0.485426827
531,GO:1903034,regulation of response to wounding,Immunity,-4.7,-3.7,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.232660757,-0.925999419
539,GO:0002440,production of molecular mediator of immune response,Immunity,-5,-4,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.321928095,-0.847996907
541,GO:0042110,T cell activation,Immunity,-5,-4,0,-2,1,-2,-1,Negativo,Negativo,-2.321928095,-1
542,GO:0045088,regulation of innate immune response,Immunity,-5,-4,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-2.321928095,-1.070389328
543,GO:0032602,chemokine production,Immunity,-5,-4,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.321928095,-1.137503524
546,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,Immunity,-5,-4,0,-2.8,1,-2.8,-1.8,Negativo,Negativo,-2.321928095,-1.485426827
553,GO:0032642,regulation of chemokine production,Immunity,-5.1,-4.1,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.350497247,-0.847996907
554,GO:0050863,regulation of T cell activation,Immunity,-5.1,-4.1,0,-2,1,-2,-1,Negativo,Negativo,-2.350497247,-1
556,GO:0046631,alpha-beta T cell activation,Immunity,-5.1,-4.1,0,-2.9,1,-2.9,-1.9,Negativo,Negativo,-2.350497247,-1.5360529
565,GO:0071706,tumor necrosis factor superfamily cytokine production,Immunity,-5.2,-4.2,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-2.378511623,-1.378511623
568,GO:0032760,positive regulation of tumor necrosis factor production,Immunity,-5.2,-4.2,0,-2.9,1,-2.9,-1.9,Negativo,Negativo,-2.378511623,-1.5360529
573,GO:0050868,negative regulation of T cell activation,Immunity,-5.3,-4.3,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.40599236,-1.201633861
574,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,Immunity,-5.3,-4.3,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-2.40599236,-1.378511623
576,GO:0002685,regulation of leukocyte migration,Immunity,-5.4,-4.4,0,-2,1,-2,-1,Negativo,Negativo,-2.432959407,-1
577,GO:0045582,positive regulation of T cell differentiation,Immunity,-5.4,-4.4,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.432959407,-1.137503524
579,GO:0032640,tumor necrosis factor production,Immunity,-5.4,-4.4,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-2.432959407,-1.378511623
582,GO:0002700,regulation of production of molecular mediator of immune response,Immunity,-5.5,-4.5,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.459431619,-1.137503524
584,GO:0002819,regulation of adaptive immune response,Immunity,-5.5,-4.5,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-2.459431619,-1.321928095
585,GO:0002687,positive regulation of leukocyte migration,Immunity,-5.5,-4.5,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-2.459431619,-1.321928095
587,GO:0032680,regulation of tumor necrosis factor production,Immunity,-5.5,-4.5,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-2.459431619,-1.378511623
589,GO:0002768,immune response-regulating cell surface receptor signaling pathway,Immunity,-5.6,-4.6,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.485426827,-0.263034406
590,GO:0050852,T cell receptor signaling pathway,Immunity,-5.6,-4.6,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-2.485426827,-0.378511623
592,GO:0002703,regulation of leukocyte mediated immunity,Immunity,-5.6,-4.6,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.485426827,-0.925999419
593,GO:0002696,positive regulation of leukocyte activation,Immunity,-5.6,-4.6,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.485426827,-1.137503524
594,GO:0002706,regulation of lymphocyte mediated immunity,Immunity,-5.6,-4.6,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.485426827,-1.137503524
595,GO:0051251,positive regulation of lymphocyte activation,Immunity,-5.6,-4.6,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.485426827,-1.201633861
597,GO:0002702,positive regulation of production of molecular mediator of immune response,Immunity,-5.7,-4.7,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.510961919,-0.847996907
600,GO:1902107,positive regulation of leukocyte differentiation,Immunity,-5.7,-4.7,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.510961919,-1.201633861
603,GO:0002764,immune response-regulating signaling pathway,Immunity,-5.8,-4.8,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.5360529,-0.263034406
606,GO:0050778,positive regulation of immune response,Immunity,-5.9,-4.9,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.560714954,-0.847996907
607,GO:0072676,lymphocyte migration,Immunity,-5.9,-4.9,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.560714954,-0.847996907
608,GO:0019955,cytokine binding,Immunity,-5.9,-4.9,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-2.560714954,-1.432959407
611,GO:0002697,regulation of immune effector process,Immunity,-6,-5,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.584962501,-0.925999419
612,GO:0002429,immune response-activating cell surface receptor signaling pathway,Immunity,-6.1,-5.1,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.608809243,-0.263034406
613,GO:0002757,immune response-activating signal transduction,Immunity,-6.1,-5.1,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.608809243,-0.263034406
619,GO:0002285,lymphocyte activation involved in immune response,Immunity,-6.1,-5.1,0,-2,1,-2,-1,Negativo,Negativo,-2.608809243,-1
622,GO:1903037,regulation of leukocyte cell-cell adhesion,Immunity,-6.2,-5.2,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-2.632268215,-1.070389328
623,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,Immunity,-6.2,-5.2,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-2.632268215,-1.321928095
626,GO:0046634,regulation of alpha-beta T cell activation,Immunity,-6.2,-5.2,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-2.632268215,-1.432959407
627,GO:1901224,positive regulation of NIK/NF-kappaB signaling,Immunity,-6.2,-5.2,0,-3.9,1,-3.9,-2.9,Negativo,Negativo,-2.632268215,-1.963474124
628,GO:0046651,lymphocyte proliferation,Immunity,-6.3,-5.3,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-2.655351829,-1.378511623
629,GO:0002253,activation of immune response,Immunity,-6.4,-5.4,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-2.678071905,-0.485426827
630,GO:0030593,neutrophil chemotaxis,Immunity,-6.4,-5.4,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-2.678071905,-1.432959407
633,GO:0042098,T cell proliferation,Immunity,-6.5,-5.5,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.700439718,-1.201633861
634,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,Immunity,-6.5,-5.5,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-2.700439718,-1.321928095
635,GO:0030101,natural killer cell activation,Immunity,-6.5,-5.5,0,-3.4,1,-3.4,-2.4,Negativo,Negativo,-2.700439718,-1.765534746
638,GO:0002250,adaptive immune response,Immunity,-6.6,-5.6,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.722466024,-1.137503524
639,GO:0050870,positive regulation of T cell activation,Immunity,-6.6,-5.6,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.722466024,-1.201633861
648,GO:0030595,leukocyte chemotaxis,Immunity,-6.8,-5.8,0,-2.8,1,-2.8,-1.8,Negativo,Negativo,-2.765534746,-1.485426827
649,GO:0097028,dendritic cell differentiation,Immunity,-6.8,-5.8,0,-3.1,1,-3.1,-2.1,Negativo,Negativo,-2.765534746,-1.632268215
651,GO:0002699,positive regulation of immune effector process,Immunity,-6.9,-5.9,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.786596362,-0.678071905
652,GO:0002260,lymphocyte homeostasis,Immunity,-6.9,-5.9,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.786596362,-1.137503524
653,GO:0070661,leukocyte proliferation,Immunity,-6.9,-5.9,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-2.786596362,-1.432959407
657,GO:0002263,cell activation involved in immune response,Immunity,-7,-6,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.807354922,-0.678071905
660,GO:0046638,positive regulation of alpha-beta T cell differentiation,Immunity,-7,-6,0,-2.9,1,-2.9,-1.9,Negativo,Negativo,-2.807354922,-1.5360529
661,GO:0002366,leukocyte activation involved in immune response,Immunity,-7.1,-6.1,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.827819025,-0.678071905
662,GO:0002274,myeloid leukocyte activation,Immunity,-7.1,-6.1,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.827819025,-0.847996907
663,GO:0002449,lymphocyte mediated immunity,Immunity,-7.1,-6.1,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-2.827819025,-1.321928095
664,GO:0002444,myeloid leukocyte mediated immunity,Immunity,-7.2,-6.2,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-2.847996907,-0.485426827
665,GO:0002275,myeloid cell activation involved in immune response,Immunity,-7.2,-6.2,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.847996907,-0.584962501
667,GO:0043299,leukocyte degranulation,Immunity,-7.3,-6.3,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-2.867896464,-0.485426827
668,GO:0032609,interferon-gamma production,Immunity,-7.3,-6.3,0,-3,1,-3,-2,Negativo,Negativo,-2.867896464,-1.584962501
669,GO:0070671,response to interleukin-12,Immunity,-7.4,-6.4,0,-2,1,-2,-1,Negativo,Negativo,-2.887525271,-1
670,GO:0002228,natural killer cell mediated immunity,Immunity,-7.4,-6.4,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.887525271,-1.201633861
671,GO:0032623,interleukin-2 production,Immunity,-7.4,-6.4,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-2.887525271,-1.321928095
672,GO:1990869,cellular response to chemokine,Immunity,-7.4,-6.4,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-2.887525271,-1.432959407
673,GO:1990868,response to chemokine,Immunity,-7.4,-6.4,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-2.887525271,-1.432959407
675,GO:1903039,positive regulation of leukocyte cell-cell adhesion,Immunity,-7.5,-6.5,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-2.906890596,-1.263034406
677,GO:0071621,granulocyte chemotaxis,Immunity,-7.5,-6.5,0,-3.4,1,-3.4,-2.4,Negativo,Negativo,-2.906890596,-1.765534746
678,GO:0036230,granulocyte activation,Immunity,-7.6,-6.6,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.925999419,-0.678071905
679,GO:0071349,cellular response to interleukin-12,Immunity,-7.6,-6.6,0,-2,1,-2,-1,Negativo,Negativo,-2.925999419,-1
680,GO:0042267,natural killer cell mediated cytotoxicity,Immunity,-7.6,-6.6,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-2.925999419,-1.263034406
681,GO:0001776,leukocyte homeostasis,Immunity,-7.6,-6.6,0,-2.9,1,-2.9,-1.9,Negativo,Negativo,-2.925999419,-1.5360529
682,GO:0002446,neutrophil mediated immunity,Immunity,-7.7,-6.7,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.944858446,-0.584962501
683,GO:1902745,positive regulation of lamellipodium organization,Immunity,-7.7,-6.7,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.944858446,-0.584962501
684,GO:0042119,neutrophil activation,Immunity,-7.7,-6.7,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.944858446,-0.678071905
686,GO:0070663,regulation of leukocyte proliferation,Immunity,-7.7,-6.7,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-2.944858446,-1.432959407
688,GO:0002821,positive regulation of adaptive immune response,Immunity,-7.8,-6.8,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.963474124,-1.201633861
689,GO:1990266,neutrophil migration,Immunity,-7.8,-6.8,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.963474124,-1.201633861
691,GO:0043030,regulation of macrophage activation,Immunity,-7.8,-6.8,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-2.963474124,-1.321928095
692,GO:0032663,regulation of interleukin-2 production,Immunity,-7.8,-6.8,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-2.963474124,-1.378511623
693,GO:0002718,regulation of cytokine production involved in immune response,Immunity,-7.8,-6.8,0,-2.9,1,-2.9,-1.9,Negativo,Negativo,-2.963474124,-1.5360529
695,GO:0043312,neutrophil degranulation,Immunity,-7.9,-6.9,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.981852653,-0.584962501
696,GO:0002283,neutrophil activation involved in immune response,Immunity,-7.9,-6.9,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.981852653,-0.584962501
699,GO:0035722,interleukin-12-mediated signaling pathway,Immunity,-8,-7,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-3,-0.765534746
700,GO:0002708,positive regulation of lymphocyte mediated immunity,Immunity,-8,-7,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-3,-0.847996907
703,GO:0032729,positive regulation of interferon-gamma production,Immunity,-8,-7,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-3,-1.432959407
704,GO:0032649,regulation of interferon-gamma production,Immunity,-8,-7,0,-2.9,1,-2.9,-1.9,Negativo,Negativo,-3,-1.5360529
707,GO:0034340,response to type I interferon,Immunity,-8,-7,0,-3.9,1,-3.9,-2.9,Negativo,Negativo,-3,-1.963474124
711,GO:0090505,epiboly involved in wound healing,Immunity,-8.2,-7.2,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-3.03562391,-0.263034406
712,GO:0044319,"wound healing, spreading of cells",Immunity,-8.2,-7.2,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-3.03562391,-0.263034406
713,GO:0097530,granulocyte migration,Immunity,-8.2,-7.2,0,-2.9,1,-2.9,-1.9,Negativo,Negativo,-3.03562391,-1.5360529
717,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,Immunity,-8.3,-7.3,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-3.053111336,-1.201633861
718,GO:0019724,B cell mediated immunity,Immunity,-8.3,-7.3,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-3.053111336,-1.263034406
719,GO:0002456,T cell mediated immunity,Immunity,-8.3,-7.3,0,-3.1,1,-3.1,-2.1,Negativo,Negativo,-3.053111336,-1.632268215
723,GO:0002715,regulation of natural killer cell mediated immunity,Immunity,-8.5,-7.5,0,-1.1,1,-1.1,-0.1,Negativo,Negativo,-3.087462841,-0.137503524
725,GO:0002705,positive regulation of leukocyte mediated immunity,Immunity,-8.5,-7.5,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-3.087462841,-0.765534746
726,GO:0016064,immunoglobulin mediated immune response,Immunity,-8.5,-7.5,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-3.087462841,-1.201633861
727,GO:0043029,T cell homeostasis,Immunity,-8.5,-7.5,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-3.087462841,-1.201633861
728,GO:0060337,type I interferon signaling pathway,Immunity,-8.5,-7.5,0,-3.7,1,-3.7,-2.7,Negativo,Negativo,-3.087462841,-1.887525271
729,GO:0071357,cellular response to type I interferon,Immunity,-8.5,-7.5,0,-3.7,1,-3.7,-2.7,Negativo,Negativo,-3.087462841,-1.887525271
730,GO:0042269,regulation of natural killer cell mediated cytotoxicity,Immunity,-8.8,-7.8,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-3.137503524,-0.263034406
731,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",Immunity,-8.8,-7.8,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-3.137503524,-0.485426827
735,GO:0006959,humoral immune response,Immunity,-9.1,-8.1,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-3.185866545,-1.137503524
738,GO:0050671,positive regulation of lymphocyte proliferation,Immunity,-9.2,-8.2,0,-3.3,1,-3.3,-2.3,Negativo,Negativo,-3.201633861,-1.722466024
740,GO:0140375,immune receptor activity,Immunity,-9.3,-8.3,0,-2,1,-2,-1,Negativo,Negativo,-3.217230716,-1
741,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,Immunity,-9.3,-8.3,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-3.217230716,-1.201633861
745,GO:0150076,neuroinflammatory response,Immunity,-9.5,-8.5,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-3.247927513,-0.925999419
746,GO:1902622,regulation of neutrophil migration,Immunity,-9.5,-8.5,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-3.247927513,-0.925999419
747,GO:0046635,positive regulation of alpha-beta T cell activation,Immunity,-9.5,-8.5,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-3.247927513,-1.201633861
748,GO:0002720,positive regulation of cytokine production involved in immune response,Immunity,-9.5,-8.5,0,-2.8,1,-2.8,-1.8,Negativo,Negativo,-3.247927513,-1.485426827
749,GO:0002286,T cell activation involved in immune response,Immunity,-9.6,-8.6,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-3.263034406,-1.378511623
751,GO:0045824,negative regulation of innate immune response,Immunity,-9.7,-8.7,0,-3.5,1,-3.5,-2.5,Negativo,Negativo,-3.277984747,-1.807354922
752,GO:0002709,regulation of T cell mediated immunity,Immunity,-9.9,-8.9,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-3.307428525,-1.321928095
753,GO:0019882,antigen processing and presentation,Immunity,-10,-9,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-3.321928095,-0.678071905
756,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,Immunity,-10,-9,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-3.321928095,-0.847996907
758,GO:0001909,leukocyte mediated cytotoxicity,Immunity,-10,-9,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-3.321928095,-0.925999419
759,GO:0042116,macrophage activation,Immunity,-10,-9,0,-3.2,1,-3.2,-2.2,Negativo,Negativo,-3.321928095,-1.678071905
760,GO:0070665,positive regulation of leukocyte proliferation,Immunity,-10,-9,0,-3.3,1,-3.3,-2.3,Negativo,Negativo,-3.321928095,-1.722466024
761,GO:0048002,antigen processing and presentation of peptide antigen,Immunity,-11,-10,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-3.459431619,-0.485426827
762,GO:0001910,regulation of leukocyte mediated cytotoxicity,Immunity,-11,-10,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-3.459431619,-0.485426827
770,GO:0002920,regulation of humoral immune response,Immunity,-12,-11,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-3.584962501,-0.847996907
772,GO:0034341,response to interferon-gamma,Immunity,-12,-11,0,-4.1,1,-4.1,-3.1,Negativo,Negativo,-3.584962501,-2.03562391
773,GO:0071346,cellular response to interferon-gamma,Immunity,-12,-11,0,-4.3,1,-4.3,-3.3,Negativo,Negativo,-3.584962501,-2.10433666
774,GO:0002347,response to tumor cell,Immunity,-13,-12,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-3.700439718,-0.485426827
777,GO:0006956,complement activation,Immunity,-13,-12,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-3.700439718,-0.925999419
778,GO:0002711,positive regulation of T cell mediated immunity,Immunity,-13,-12,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-3.700439718,-1.378511623
780,GO:0019956,chemokine binding,Immunity,-14,-13,0,-3.1,1,-3.1,-2.1,Negativo,Negativo,-3.807354922,-1.632268215
781,GO:0032703,negative regulation of interleukin-2 production,Immunity,-14,-13,0,-3.3,1,-3.3,-2.3,Negativo,Negativo,-3.807354922,-1.722466024
782,GO:0002455,humoral immune response mediated by circulating immunoglobulin,Immunity,-15,-14,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-3.906890596,-1.263034406
783,GO:0030449,regulation of complement activation,Immunity,-15,-14,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-3.906890596,-1.263034406
784,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,Immunity,-15,-14,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-3.906890596,-1.378511623
785,GO:0006958,"complement activation, classical pathway",Immunity,-15,-14,0,-3.6,1,-3.6,-2.6,Negativo,Negativo,-3.906890596,-1.847996907
786,GO:0009595,detection of biotic stimulus,Immunity,-15,-14,0,-3.7,1,-3.7,-2.7,Negativo,Negativo,-3.906890596,-1.887525271
787,GO:0060333,interferon-gamma-mediated signaling pathway,Immunity,-15,-14,0,-5.2,1,-5.2,-4.2,Negativo,Negativo,-3.906890596,-2.378511623
792,GO:0001913,T cell mediated cytotoxicity,Immunity,-17,-16,0,-2,1,-2,-1,Negativo,Negativo,-4.087462841,-1
797,GO:0002281,macrophage activation involved in immune response,Immunity,-18,-17,0,-4.8,1,-4.8,-3.8,Negativo,Negativo,-4.169925001,-2.263034406
798,GO:0001914,regulation of T cell mediated cytotoxicity,Immunity,-19,-18,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-4.247927513,-0.485426827
804,GO:0003823,antigen binding,Immunity,-24,-23,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-4.584962501,-0.925999419
806,GO:0002468,dendritic cell antigen processing and presentation,Immunity,-24,-23,0,-3.3,1,-3.3,-2.3,Negativo,Negativo,-4.584962501,-1.722466024
809,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,Immunity,-25,-24,0,-5.6,1,-5.6,-4.6,Negativo,Negativo,-4.64385619,-2.485426827
815,GO:0019883,antigen processing and presentation of endogenous antigen,Immunity,-30,-29,0,-3.8,1,-3.8,-2.8,Negativo,Negativo,-4.906890596,-1.925999419
816,GO:0002483,antigen processing and presentation of endogenous peptide antigen,Immunity,-31,-30,0,-4.8,1,-4.8,-3.8,Negativo,Negativo,-4.95419631,-2.263034406
818,GO:0042612,MHC class I protein complex,Immunity,-44,-43,0,-4,1,-4,-3,Negativo,Negativo,-5.459431619,-2
819,GO:0002480,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",Immunity,-44,-43,0,-4.5,1,-4.5,-3.5,Negativo,Negativo,-5.459431619,-2.169925001
820,GO:0042611,MHC protein complex,Immunity,-53,-52,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-5.727920455,-1.201633861
690,GO:0002886,regulation of myeloid leukocyte mediated immunity,Immunity,-7.8,-6.8,2.3,0,1,2.3,1.3,Negativo,Positivo,-2.963474124,1.201633861
817,GO:0042605,peptide antigen binding,Immunity,-38,-37,1.6,0,1,1.6,0.6,Negativo,Positivo,-5.247927513,0.678071905
419,GO:0000139,Golgi membrane,Metabolism-Homeostasis,-1.9,-0.9,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-0.925999419,-0.378511623
423,GO:0044089,positive regulation of cellular component biogenesis,Metabolism-Homeostasis,-2.4,-1.4,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-1.263034406,-0.263034406
429,GO:0043687,post-translational protein modification,Metabolism-Homeostasis,-2.6,-1.6,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-1.378511623,-0.378511623
442,GO:0030162,regulation of proteolysis,Metabolism-Homeostasis,-3,-2,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-1.584962501,-0.485426827
461,GO:0007033,vacuole organization,Metabolism-Homeostasis,-3.3,-2.3,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-1.722466024,-0.263034406
463,GO:0034620,cellular response to unfolded protein,Metabolism-Homeostasis,-3.4,-2.4,0,-1.1,1,-1.1,-0.1,Negativo,Negativo,-1.765534746,-0.137503524
476,GO:1903706,regulation of hemopoiesis,Metabolism-Homeostasis,-3.7,-2.7,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-1.887525271,-0.584962501
478,GO:0031901,early endosome membrane,Metabolism-Homeostasis,-3.8,-2.8,0,-2,1,-2,-1,Negativo,Negativo,-1.925999419,-1
518,GO:0005774,vacuolar membrane,Metabolism-Homeostasis,-4.5,-3.5,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.169925001,-0.263034406
523,GO:0005773,vacuole,Metabolism-Homeostasis,-4.6,-3.6,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.201633861,-0.584962501
549,GO:0098852,lytic vacuole membrane,Metabolism-Homeostasis,-5.1,-4.1,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-2.350497247,-0.378511623
550,GO:0005765,lysosomal membrane,Metabolism-Homeostasis,-5.1,-4.1,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-2.350497247,-0.378511623
558,GO:0005764,lysosome,Metabolism-Homeostasis,-5.2,-4.2,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.378511623,-0.678071905
559,GO:0000323,lytic vacuole,Metabolism-Homeostasis,-5.2,-4.2,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.378511623,-0.678071905
560,GO:0051881,regulation of mitochondrial membrane potential,Metabolism-Homeostasis,-5.2,-4.2,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.378511623,-0.925999419
601,GO:1903708,positive regulation of hemopoiesis,Metabolism-Homeostasis,-5.7,-4.7,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.510961919,-1.201633861
676,GO:0004177,aminopeptidase activity,Metabolism-Homeostasis,-7.5,-6.5,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-2.906890596,-1.263034406
789,GO:0071402,cellular response to lipoprotein particle stimulus,Metabolism-Homeostasis,-16,-15,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-4,-1.321928095
793,GO:0055094,response to lipoprotein particle,Metabolism-Homeostasis,-17,-16,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-4.087462841,-1.378511623
422,GO:0043270,positive regulation of ion transport,Metabolism-Homeostasis,-2.2,-1.2,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-1.137503524,-0.678071905
424,GO:0032787,monocarboxylic acid metabolic process,Metabolism-Homeostasis,-2.4,-1.4,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-1.263034406,-0.378511623
428,GO:1903793,positive regulation of anion transport,Metabolism-Homeostasis,-2.5,-1.5,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-1.321928095,-0.678071905
432,GO:0006631,fatty acid metabolic process,Metabolism-Homeostasis,-2.8,-1.8,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-1.485426827,-0.678071905
460,GO:0046390,ribose phosphate biosynthetic process,Metabolism-Homeostasis,-3.3,-2.3,0,-1.1,1,-1.1,-0.1,Negativo,Negativo,-1.722466024,-0.137503524
516,GO:0030004,cellular monovalent inorganic cation homeostasis,Metabolism-Homeostasis,-4.4,-3.4,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.137503524,-0.925999419
519,GO:0002223,stimulatory C-type lectin receptor signaling pathway,Metabolism-Homeostasis,-4.5,-3.5,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.169925001,-0.263034406
530,GO:1902936,phosphatidylinositol bisphosphate binding,Metabolism-Homeostasis,-4.7,-3.7,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.232660757,-0.584962501
534,GO:0050810,regulation of steroid biosynthetic process,Metabolism-Homeostasis,-4.8,-3.8,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.263034406,-0.678071905
538,GO:0000041,transition metal ion transport,Metabolism-Homeostasis,-5,-4,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-2.321928095,-0.485426827
551,GO:0033238,regulation of cellular amine metabolic process,Metabolism-Homeostasis,-5.1,-4.1,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.350497247,-0.584962501
569,GO:0043112,receptor metabolic process,Metabolism-Homeostasis,-5.3,-4.3,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.40599236,-0.847996907
583,GO:0055076,transition metal ion homeostasis,Metabolism-Homeostasis,-5.5,-4.5,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.459431619,-1.137503524
598,GO:0046916,cellular transition metal ion homeostasis,Metabolism-Homeostasis,-5.7,-4.7,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.510961919,-0.925999419
605,GO:0016667,"oxidoreductase activity, acting on a sulfur group of donors",Metabolism-Homeostasis,-5.9,-4.9,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-2.560714954,-0.378511623
616,GO:0005546,"phosphatidylinositol-4,5-bisphosphate binding",Metabolism-Homeostasis,-6.1,-5.1,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.608809243,-0.584962501
646,GO:0051926,negative regulation of calcium ion transport,Metabolism-Homeostasis,-6.8,-5.8,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.765534746,-0.925999419
674,GO:0055072,iron ion homeostasis,Metabolism-Homeostasis,-7.5,-6.5,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-2.906890596,-1.070389328
698,GO:0006879,cellular iron ion homeostasis,Metabolism-Homeostasis,-8,-7,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-3,-0.584962501
701,GO:0015485,cholesterol binding,Metabolism-Homeostasis,-8,-7,0,-2,1,-2,-1,Negativo,Negativo,-3,-1
715,GO:0032934,sterol binding,Metabolism-Homeostasis,-8.3,-7.3,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-3.053111336,-0.765534746
724,GO:0010712,regulation of collagen metabolic process,Metabolism-Homeostasis,-8.5,-7.5,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-3.087462841,-0.485426827
739,GO:0016209,antioxidant activity,Metabolism-Homeostasis,-9.3,-8.3,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-3.217230716,-0.925999419
743,GO:0048306,calcium-dependent protein binding,Metabolism-Homeostasis,-9.5,-8.5,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-3.247927513,-0.485426827
768,GO:0004364,glutathione transferase activity,Metabolism-Homeostasis,-11,-10,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-3.459431619,-1.321928095
776,GO:0008198,ferrous iron binding,Metabolism-Homeostasis,-13,-12,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-3.700439718,-0.678071905
805,GO:0055102,lipase inhibitor activity,Metabolism-Homeostasis,-24,-23,0,-2.6,1,-2.6,-1.6,Negativo,Negativo,-4.584962501,-1.378511623
814,GO:0004859,phospholipase inhibitor activity,Metabolism-Homeostasis,-30,-29,0,-3.6,1,-3.6,-2.6,Negativo,Negativo,-4.906890596,-1.847996907
502,GO:0015748,organophosphate ester transport,Metabolism-Homeostasis,-4.1,-3.1,1.5,0,1,1.5,0.5,Negativo,Positivo,-2.03562391,0.584962501
535,GO:0015914,phospholipid transport,Metabolism-Homeostasis,-4.9,-3.9,1.3,0,1,1.3,0.3,Negativo,Positivo,-2.292781749,0.378511623
537,GO:0009201,ribonucleoside triphosphate biosynthetic process,Metabolism-Homeostasis,-5,-4,1.3,0,1,1.3,0.3,Negativo,Positivo,-2.321928095,0.378511623
580,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,Metabolism-Homeostasis,-5.5,-4.5,1.1,0,1,1.1,0.1,Negativo,Positivo,-2.459431619,0.137503524
706,GO:0033293,monocarboxylic acid binding,Metabolism-Homeostasis,-8,-7,2.9,0,1,2.9,1.9,Negativo,Positivo,-3,1.5360529
763,GO:0032366,intracellular sterol transport,Metabolism-Homeostasis,-11,-10,1.4,0,1,1.4,0.4,Negativo,Positivo,-3.459431619,0.485426827
764,GO:0032367,intracellular cholesterol transport,Metabolism-Homeostasis,-11,-10,1.4,0,1,1.4,0.4,Negativo,Positivo,-3.459431619,0.485426827
791,GO:0030574,collagen catabolic process,Metabolism-Homeostasis,-17,-16,1.2,0,1,1.2,0.2,Negativo,Positivo,-4.087462841,0.263034406
807,GO:2000644,regulation of receptor catabolic process,Metabolism-Homeostasis,-24,-23,4.5,0,1,4.5,3.5,Negativo,Positivo,-4.584962501,2.169925001
813,GO:0019372,lipoxygenase pathway,Metabolism-Homeostasis,-30,-29,2.5,0,1,2.5,1.5,Negativo,Positivo,-4.906890596,1.321928095
666,GO:0048678,response to axon injury,Neural,-7.2,-6.2,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.847996907,-0.584962501
705,GO:0048708,astrocyte differentiation,Neural,-8,-7,0,-2.9,1,-2.9,-1.9,Negativo,Negativo,-3,-1.5360529
742,GO:0014009,glial cell proliferation,Neural,-9.4,-8.4,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-3.232660757,-0.765534746
796,GO:0001774,microglial cell activation,Neural,-18,-17,0,-3.9,1,-3.9,-2.9,Negativo,Negativo,-4.169925001,-1.963474124
799,GO:0048143,astrocyte activation,Neural,-19,-18,0,-3,1,-3,-2,Negativo,Negativo,-4.247927513,-1.584962501
352,GO:0097107,postsynaptic density assembly,Neural,19,18,6.4,0,1,6.4,5.4,Positivo,Positivo,4.247927513,2.678071905
357,GO:0098698,postsynaptic specialization assembly,Neural,16,15,5.5,0,1,5.5,4.5,Positivo,Positivo,4,2.459431619
358,GO:0097106,postsynaptic density organization,Neural,15,14,5.8,0,1,5.8,4.8,Positivo,Positivo,3.906890596,2.5360529
360,GO:1904861,excitatory synapse assembly,Neural,14,13,5.2,0,1,5.2,4.2,Positivo,Positivo,3.807354922,2.378511623
361,GO:0099084,postsynaptic specialization organization,Neural,14,13,5.5,0,1,5.5,4.5,Positivo,Positivo,3.807354922,2.459431619
377,GO:0099068,postsynapse assembly,Neural,11,10,5.6,0,1,5.6,4.6,Positivo,Positivo,3.459431619,2.485426827
382,GO:0099061,integral component of postsynaptic density membrane,Neural,7.9,6.9,2.7,0,1,2.7,1.7,Positivo,Positivo,2.981852653,1.432959407
399,GO:0099146,intrinsic component of postsynaptic density membrane,Neural,7.3,6.3,2.5,0,1,2.5,1.5,Positivo,Positivo,2.867896464,1.321928095
403,GO:0098839,postsynaptic density membrane,Neural,5.4,4.4,2.2,0,1,2.2,1.2,Positivo,Positivo,2.432959407,1.137503524
408,GO:0030516,regulation of axon extension,Neural,4.9,3.9,2.5,0,1,2.5,1.5,Positivo,Positivo,2.292781749,1.321928095
426,GO:0048471,perinuclear region of cytoplasm,Other,-2.4,-1.4,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-1.263034406,-0.847996907
427,GO:0019900,kinase binding,Other,-2.5,-1.5,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-1.321928095,-0.485426827
430,GO:0019058,viral life cycle,Other,-2.7,-1.7,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-1.432959407,-0.765534746
431,GO:0022411,cellular component disassembly,Other,-2.8,-1.8,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-1.485426827,-0.378511623
433,GO:0010638,positive regulation of organelle organization,Other,-2.9,-1.9,0,-1.1,1,-1.1,-0.1,Negativo,Negativo,-1.5360529,-0.137503524
446,GO:0010639,negative regulation of organelle organization,Other,-3.1,-2.1,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-1.632268215,-0.263034406
447,GO:2001234,negative regulation of apoptotic signaling pathway,Other,-3.1,-2.1,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-1.632268215,-0.847996907
464,GO:2000116,regulation of cysteine-type endopeptidase activity,Other,-3.5,-2.5,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-1.807354922,-0.765534746
471,GO:0006605,protein targeting,Other,-3.6,-2.6,0,-1,1,-1,0,Negativo,Negativo,-1.847996907,0
472,GO:0061025,membrane fusion,Other,-3.6,-2.6,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-1.847996907,-0.678071905
473,GO:0006897,endocytosis,Other,-3.6,-2.6,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-1.847996907,-0.925999419
475,GO:0043254,regulation of protein-containing complex assembly,Other,-3.7,-2.7,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-1.887525271,-0.263034406
482,GO:0043903,regulation of biological process involved in symbiotic interaction,Other,-3.9,-2.9,0,-2,1,-2,-1,Negativo,Negativo,-1.963474124,-1
487,GO:0050792,regulation of viral process,Other,-4,-3,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2,-0.925999419
491,GO:0052126,movement in host environment,Other,-4,-3,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2,-1.201633861
501,GO:0031333,negative regulation of protein-containing complex assembly,Other,-4.1,-3.1,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-2.03562391,-0.485426827
504,GO:0030218,erythrocyte differentiation,Other,-4.2,-3.2,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-2.070389328,-0.263034406
506,GO:0031099,regeneration,Other,-4.2,-3.2,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.070389328,-0.847996907
507,GO:0030100,regulation of endocytosis,Other,-4.3,-3.3,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-2.10433666,-0.765534746
508,GO:0055037,recycling endosome,Other,-4.3,-3.3,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-2.10433666,-0.765534746
510,GO:0010008,endosome membrane,Other,-4.3,-3.3,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.10433666,-0.847996907
517,GO:0009897,external side of plasma membrane,Other,-4.4,-3.4,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-2.137503524,-1.432959407
524,GO:1903900,regulation of viral life cycle,Other,-4.6,-3.6,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-2.201633861,-1.263034406
527,GO:0030136,clathrin-coated vesicle,Other,-4.7,-3.7,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-2.232660757,-0.378511623
529,GO:0002262,myeloid cell homeostasis,Other,-4.7,-3.7,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.232660757,-0.584962501
532,GO:0005770,late endosome,Other,-4.7,-3.7,0,-2,1,-2,-1,Negativo,Negativo,-2.232660757,-1
533,GO:0034101,erythrocyte homeostasis,Other,-4.8,-3.8,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-2.263034406,-0.378511623
536,GO:0048872,homeostasis of number of cells,Other,-4.9,-3.9,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.292781749,-0.847996907
544,GO:0001726,ruffle,Other,-5,-4,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-2.321928095,-1.263034406
555,GO:0048144,fibroblast proliferation,Other,-5.1,-4.1,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-2.350497247,-1.321928095
562,GO:0048145,regulation of fibroblast proliferation,Other,-5.2,-4.2,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.378511623,-1.201633861
563,GO:0030055,cell-substrate junction,Other,-5.2,-4.2,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-2.378511623,-1.263034406
570,GO:2000117,negative regulation of cysteine-type endopeptidase activity,Other,-5.3,-4.3,0,-2,1,-2,-1,Negativo,Negativo,-2.40599236,-1
571,GO:0098552,side of membrane,Other,-5.3,-4.3,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-2.40599236,-1.070389328
578,GO:0050867,positive regulation of cell activation,Other,-5.4,-4.4,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.432959407,-1.201633861
581,GO:0006898,receptor-mediated endocytosis,Other,-5.5,-4.5,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.459431619,-0.847996907
591,GO:0031902,late endosome membrane,Other,-5.6,-4.6,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.485426827,-0.678071905
596,GO:0031623,receptor internalization,Other,-5.7,-4.7,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.510961919,-0.847996907
599,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,Other,-5.7,-4.7,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.510961919,-0.925999419
602,GO:0048525,negative regulation of viral process,Other,-5.7,-4.7,0,-2.8,1,-2.8,-1.8,Negativo,Negativo,-2.510961919,-1.485426827
604,GO:0043242,negative regulation of protein-containing complex disassembly,Other,-5.8,-4.8,0,-2.3,1,-2.3,-1.3,Negativo,Negativo,-2.5360529,-1.201633861
617,GO:0030139,endocytic vesicle,Other,-6.1,-5.1,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-2.608809243,-0.678071905
618,GO:0048259,regulation of receptor-mediated endocytosis,Other,-6.1,-5.1,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-2.608809243,-0.765534746
620,GO:0031091,platelet alpha granule,Other,-6.1,-5.1,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.608809243,-1.137503524
625,GO:0032943,mononuclear cell proliferation,Other,-6.2,-5.2,0,-2.7,1,-2.7,-1.7,Negativo,Negativo,-2.632268215,-1.432959407
632,GO:0045335,phagocytic vesicle,Other,-6.5,-5.5,0,-2.2,1,-2.2,-1.2,Negativo,Negativo,-2.700439718,-1.137503524
636,GO:0045851,pH reduction,Other,-6.6,-5.6,0,-1.7,1,-1.7,-0.7,Negativo,Negativo,-2.722466024,-0.765534746
637,GO:0042246,tissue regeneration,Other,-6.6,-5.6,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.722466024,-0.847996907
644,GO:0101003,ficolin-1-rich granule membrane,Other,-6.8,-5.8,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.765534746,-0.847996907
645,GO:0051452,intracellular pH reduction,Other,-6.8,-5.8,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-2.765534746,-0.847996907
647,GO:0031093,platelet alpha granule lumen,Other,-6.8,-5.8,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-2.765534746,-1.070389328
650,GO:0031983,vesicle lumen,Other,-6.9,-5.9,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-2.786596362,-0.584962501
654,GO:0055038,recycling endosome membrane,Other,-7,-6,0,-1.1,1,-1.1,-0.1,Negativo,Negativo,-2.807354922,-0.137503524
655,GO:0034774,secretory granule lumen,Other,-7,-6,0,-1.3,1,-1.3,-0.3,Negativo,Negativo,-2.807354922,-0.378511623
656,GO:0060205,cytoplasmic vesicle lumen,Other,-7,-6,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-2.807354922,-0.485426827
658,GO:0080171,lytic vacuole organization,Other,-7,-6,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.807354922,-0.925999419
659,GO:0007040,lysosome organization,Other,-7,-6,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-2.807354922,-0.925999419
687,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,Other,-7.7,-6.7,0,-2.8,1,-2.8,-1.8,Negativo,Negativo,-2.944858446,-1.485426827
694,GO:0101002,ficolin-1-rich granule,Other,-7.9,-6.9,0,-1.1,1,-1.1,-0.1,Negativo,Negativo,-2.981852653,-0.137503524
697,GO:0090504,epiboly,Other,-8,-7,0,-1.1,1,-1.1,-0.1,Negativo,Negativo,-3,-0.137503524
702,GO:0090382,phagosome maturation,Other,-8,-7,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-3,-1.070389328
710,GO:0031227,intrinsic component of endoplasmic reticulum membrane,Other,-8.2,-7.2,0,-1.2,1,-1.2,-0.2,Negativo,Negativo,-3.03562391,-0.263034406
714,GO:1903902,positive regulation of viral life cycle,Other,-8.2,-7.2,0,-3,1,-3,-2,Negativo,Negativo,-3.03562391,-1.584962501
716,GO:0006909,phagocytosis,Other,-8.3,-7.3,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-3.053111336,-1.070389328
720,GO:0045807,positive regulation of endocytosis,Other,-8.4,-7.4,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-3.070389328,-0.847996907
721,GO:0001906,cell killing,Other,-8.4,-7.4,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-3.070389328,-1.070389328
722,GO:0030176,integral component of endoplasmic reticulum membrane,Other,-8.5,-7.5,0,-1.1,1,-1.1,-0.1,Negativo,Negativo,-3.087462841,-0.137503524
732,GO:0031341,regulation of cell killing,Other,-8.8,-7.8,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-3.137503524,-1.070389328
733,GO:0010324,membrane invagination,Other,-9,-8,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-3.169925001,-0.485426827
734,GO:0030670,phagocytic vesicle membrane,Other,-9,-8,0,-2.5,1,-2.5,-1.5,Negativo,Negativo,-3.169925001,-1.321928095
736,GO:0032946,positive regulation of mononuclear cell proliferation,Other,-9.1,-8.1,0,-3.4,1,-3.4,-2.4,Negativo,Negativo,-3.185866545,-1.765534746
737,GO:1902743,regulation of lamellipodium organization,Other,-9.2,-8.2,0,-2.1,1,-2.1,-1.1,Negativo,Negativo,-3.201633861,-1.070389328
744,GO:0043403,skeletal muscle tissue regeneration,Other,-9.5,-8.5,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-3.247927513,-0.847996907
750,GO:0005775,vacuolar lumen,Other,-9.7,-8.7,0,-1.5,1,-1.5,-0.5,Negativo,Negativo,-3.277984747,-0.584962501
754,GO:0099024,plasma membrane invagination,Other,-10,-9,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-3.321928095,-0.678071905
755,GO:0043202,lysosomal lumen,Other,-10,-9,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-3.321928095,-0.847996907
757,GO:0030666,endocytic vesicle membrane,Other,-10,-9,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-3.321928095,-0.925999419
765,GO:0031579,membrane raft organization,Other,-11,-10,0,-1.8,1,-1.8,-0.8,Negativo,Negativo,-3.459431619,-0.847996907
766,GO:0006911,"phagocytosis, engulfment",Other,-11,-10,0,-2,1,-2,-1,Negativo,Negativo,-3.459431619,-1
767,GO:0007035,vacuolar acidification,Other,-11,-10,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-3.459431619,-1.263034406
769,GO:0072562,blood microparticle,Other,-12,-11,0,-1.4,1,-1.4,-0.4,Negativo,Negativo,-3.584962501,-0.485426827
771,GO:0048260,positive regulation of receptor-mediated endocytosis,Other,-12,-11,0,-1.9,1,-1.9,-0.9,Negativo,Negativo,-3.584962501,-0.925999419
775,GO:0031338,regulation of vesicle fusion,Other,-13,-12,0,-1.6,1,-1.6,-0.6,Negativo,Negativo,-3.700439718,-0.678071905
779,GO:0031342,negative regulation of cell killing,Other,-14,-13,0,-2.4,1,-2.4,-1.4,Negativo,Negativo,-3.807354922,-1.263034406
794,GO:0031904,endosome lumen,Other,-17,-16,0,-3.2,1,-3.2,-2.2,Negativo,Negativo,-4.087462841,-1.678071905
795,GO:0005767,secondary lysosome,Other,-17,-16,0,-5.2,1,-5.2,-4.2,Negativo,Negativo,-4.087462841,-2.378511623
808,GO:0044754,autolysosome,Other,-24,-23,0,-5.4,1,-5.4,-4.4,Negativo,Negativo,-4.584962501,-2.432959407
812,GO:0046598,positive regulation of viral entry into host cell,Other,-27,-26,0,-3.6,1,-3.6,-2.6,Negativo,Negativo,-4.754887502,-1.847996907
480,GO:0007164,establishment of tissue polarity,Other,-3.9,-2.9,1.8,0,1,1.8,0.8,Negativo,Positivo,-1.963474124,0.847996907
481,GO:0001736,establishment of planar polarity,Other,-3.9,-2.9,1.8,0,1,1.8,0.8,Negativo,Positivo,-1.963474124,0.847996907
505,GO:0090175,regulation of establishment of planar polarity,Other,-4.2,-3.2,1.7,0,1,1.7,0.7,Negativo,Positivo,-2.070389328,0.765534746
511,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",Other,-4.3,-3.3,1.8,0,1,1.8,0.8,Negativo,Positivo,-2.10433666,0.847996907
614,GO:0051851,modulation by host of symbiont process,Other,-6.1,-5.1,1.2,0,1,1.2,0.2,Negativo,Positivo,-2.608809243,0.263034406
640,GO:0016601,Rac protein signal transduction,Other,-6.8,-5.8,1.3,0,1,1.3,0.3,Negativo,Positivo,-2.765534746,0.378511623
709,GO:0030665,clathrin-coated vesicle membrane,Other,-8.1,-7.1,1.1,0,1,1.1,0.1,Negativo,Positivo,-3.017921908,0.137503524
788,GO:1903901,negative regulation of viral life cycle,Other,-16,-15,2,0,1,2,1,Negativo,Positivo,-4,1
790,GO:0045334,clathrin-coated endocytic vesicle,Other,-17,-16,1.2,0,1,1.2,0.2,Negativo,Positivo,-4.087462841,0.263034406
800,GO:1900221,regulation of amyloid-beta clearance,Other,-20,-19,2.3,0,1,2.3,1.3,Negativo,Positivo,-4.321928095,1.201633861
803,GO:0030669,clathrin-coated endocytic vesicle membrane,Other,-24,-23,1.6,0,1,1.6,0.6,Negativo,Positivo,-4.584962501,0.678071905
379,GO:0035198,miRNA binding,Other,9.9,8.9,1.7,0,1,1.7,0.7,Positivo,Positivo,3.307428525,0.765534746
384,GO:0061980,regulatory RNA binding,Other,7.7,6.7,1.3,0,1,1.3,0.3,Positivo,Positivo,2.944858446,0.378511623
413,GO:0098727,maintenance of cell number,Other,4.6,3.6,2.7,0,1,2.7,1.7,Positivo,Positivo,2.201633861,1.432959407
316,GO:0001714,endodermal cell fate specification,Stemness,95,94,4.7,0,1,4.7,3.7,Positivo,Positivo,6.569855608,2.232660757
323,GO:0001711,endodermal cell fate commitment,Stemness,36,35,2.5,0,1,2.5,1.5,Positivo,Positivo,5.169925001,1.321928095
351,GO:0060795,cell fate commitment involved in formation of primary germ layer,Stemness,22,21,3.6,0,1,3.6,2.6,Positivo,Positivo,4.459431619,1.847996907
375,GO:0001708,cell fate specification,Stemness,11,10,1.8,0,1,1.8,0.8,Positivo,Positivo,3.459431619,0.847996907
398,GO:0001756,somitogenesis,Stemness,7.7,6.7,2.4,0,1,2.4,1.4,Positivo,Positivo,2.944858446,1.263034406
400,GO:0035019,somatic stem cell population maintenance,Stemness,6.9,5.9,4,0,1,4,3,Positivo,Positivo,2.786596362,2
404,GO:0030902,hindbrain development,Stemness,5.3,4.3,1.9,0,1,1.9,0.9,Positivo,Positivo,2.40599236,0.925999419
414,GO:0019827,stem cell population maintenance,Stemness,3.9,2.9,2.8,0,1,2.8,1.8,Positivo,Positivo,1.963474124,1.485426827
